(Q28284636)

4

Martin Ingelsson

0 references

Rudolph E. Tanzi

11

Rudolph E Tanzi

0 references

Dennis J. Selkoe

9

Dennis J Selkoe

0 references

Lars Bertram

10

Lars Bertram

0 references

Wesley Farris

6

Wesley Farris

0 references

author name string

Minji Kim

1

0 references

Louis B Hersh

2

0 references

Malcolm A Leissring

3

0 references

Toshifumi Matsui

5

0 references

Alice Lu

Journal of Biological Chemistry

7

0 references

language of work or name

English

0 references

publication date

16 March 2007

0 references

published in

0 references

volume

282

0 references

issue

11

0 references

page(s)

7825-32

0 references

cites work

Clearing the brain's amyloid cobwebs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Role of Genes and Environments for Explaining Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Insulin-degrading enzyme: embarking on amyloid destruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Genetic variation in a haplotype block spanningIDE influences Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Results of a high-resolution genome screen of 437 Alzheimer's disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Estrogen regulates neprilysin activity in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Kinetics of amyloid beta-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

The rat insulin-degrading enzyme. Molecular cloning and characterization of tissue-specific transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Insulin degradation: mechanisms, products, and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Ubiquitin in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Insulysin: an allosteric enzyme as a target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

In VitroInhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200

Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609168200